+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2026-2032- Product Image
Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5470903
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Next-Generation Sequencing Sample Preparation Market is projected to reach USD 7.10 Billion in 2026. It is expected to continue growing at a CAGR of 12.55%, reaching USD 14.52 Billion by 2032.

Next-generation sequencing sample preparation is the critical front end of every genomic workflow, converting DNA, RNA, cell-free nucleic acids, FFPE tissue, single cells, and microbial samples into sequencing-ready libraries. Because library quality directly affects read depth, variant detection, coverage uniformity, duplicate rates, and reproducibility, NGS sample preparation has become a strategic investment area for clinical laboratories, pharmaceutical developers, academic genomics centers, and public health programs.

Demand is being reinforced by the expansion of precision oncology, rare disease diagnosis, reproductive health screening, infectious disease surveillance, pharmacogenomics, and population-scale genomics. Publicly documented programs such as the U.S. All of Us Research Program, UK Biobank’s 500,000-participant cohort, Genomics England, and national genome initiatives across Asia-Pacific and the Middle East illustrate how large-scale sequencing is moving from research infrastructure into healthcare systems. Within this shift, optimized nucleic acid extraction, fragmentation, end repair, adapter ligation, target enrichment, barcoding, library amplification, and quality control are increasingly decisive for cost control and clinically reliable genomic data.

Transformative Shifts in the NGS Sample Preparation Landscape

The NGS sample preparation landscape is shifting from manual, batch-based protocols toward automated, miniaturized, and application-specific workflows. Laboratories are prioritizing kits, reagents, and instruments that reduce hands-on time, limit contamination risk, support low-input samples, and enable consistent performance across DNA sequencing, RNA sequencing, circulating tumor DNA, metagenomic sequencing, and single-cell applications.

A second transformation is the move from broad research-use workflows to regulated clinical sequencing environments. In oncology and inherited disease testing, sample preparation must align with validation requirements, quality management systems, chain-of-custody documentation, and traceability expectations. This is accelerating adoption of unique molecular identifiers, dual-indexed adapters, standardized QC checkpoints, and closed or semi-closed automation platforms that support repeatability across centralized and decentralized testing sites.

Cumulative Impact of Artificial Intelligence on Sample Preparation

Artificial intelligence is reshaping NGS sample preparation by improving protocol selection, run planning, quality prediction, and anomaly detection. AI-enabled analytics can integrate historical library yield, sample input, nucleic acid integrity, extraction method, operator variables, and sequencing metrics to predict failed libraries before costly sequencing runs occur. This is especially valuable for degraded FFPE tissue, low-volume liquid biopsy samples, microbiome specimens, and heterogeneous clinical samples.

AI is also strengthening laboratory automation by helping teams optimize reagent use, scheduling, and instrument utilization. In high-throughput sequencing environments, machine learning models can flag batch effects, identify outlier wells, and recommend corrective actions for fragmentation, amplification cycles, or enrichment conditions. The cumulative impact is not the replacement of wet-lab expertise, but the creation of more predictable, scalable, and quality-controlled NGS library preparation operations.

Key Regional Insights for NGS Sample Preparation

North America remains a leading region for NGS sample preparation adoption due to strong clinical sequencing infrastructure, a large installed base of sequencing platforms, active regulatory oversight of diagnostic technologies, and sustained public funding for biomedical research, cancer genomics, and public health sequencing. The United States drives demand through oncology panels, rare disease programs, reproductive health testing, pathogen surveillance, and biopharma companion diagnostic development, while Canada benefits from public genomics networks, provincial healthcare systems, and hospital-based precision medicine initiatives.

Europe is shaped by strong public genomics programs, national health system integration, and regulatory emphasis on quality, data governance, and diagnostic performance. The European Union’s In Vitro Diagnostic Regulation has increased attention on validated workflows, documentation, risk classification, and supplier reliability. The United Kingdom, Germany, France, Italy, and Spain continue to expand clinical and translational sequencing use cases in oncology, rare disease, pharmacogenomics, and population health, while Russia maintains scientific genomics activity despite market access and supply chain constraints.

Asia-Pacific is a rapidly evolving demand environment, supported by China’s large sequencing ecosystem, Japan’s advanced healthcare and research infrastructure, South Korea’s precision medicine capabilities, India’s expanding diagnostic market, and Australia’s genomics-enabled healthcare initiatives. Latin America, led by Brazil and Mexico, is building capacity in oncology, infectious disease sequencing, and academic genomics, although reimbursement and infrastructure variation influence adoption. The Middle East is advancing national genome and precision health programs, particularly in GCC countries, where inherited disease, population genomics, and clinical modernization are key priorities. Africa’s opportunity is tied to pathogen genomics, inherited disease research, antimicrobial resistance monitoring, and capacity-building initiatives that improve local sample processing, cold-chain management, and biospecimen quality.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

The G7 countries represent the most mature demand base for NGS sample preparation because they combine advanced healthcare systems, major public research funding, established biopharma sectors, and dense clinical laboratory networks. Their priorities center on validated sample preparation workflows for oncology, rare disease diagnostics, population health studies, infectious disease surveillance, and drug development, with growing emphasis on automation, data integrity, and reproducibility.

The European Union is increasingly important because regulatory harmonization, cross-border research collaborations, and healthcare digitization are raising expectations for standardization, traceability, and quality management across sequencing workflows. NATO markets overlap substantially with North America and Europe, creating demand for genomic surveillance, biodefense-related sequencing readiness, public health preparedness, and resilient laboratory supply chains capable of supporting rapid pathogen characterization.

BRICS countries are strategically important for long-term sequencing adoption because they combine large populations, expanding clinical diagnostics, scientific talent, and public health priorities. China and India provide scale, workforce depth, and expanding diagnostics access; Brazil and South Africa contribute regional genomics leadership in Latin America and Africa; and Russia retains scientific capacity despite geopolitical limitations. ASEAN markets are advancing through Singapore’s biomedical hub, Thailand’s medical research base, Malaysia’s diagnostics expansion, Indonesia’s population scale, and Vietnam’s growing healthcare investment. The GCC is distinguished by government-backed precision medicine, national genome programs, consanguinity-informed inherited disease research, and high interest in population genomics and preventive healthcare.

Key Country Insights for Leading NGS Sample Preparation Markets

The United States leads country-level adoption through commercial clinical sequencing, cancer genomics, biopharma partnerships, newborn and rare disease research, and public research funding. Canada’s strengths include public health genomics, national research networks, academic medical centers, and integrated healthcare systems. Mexico is expanding diagnostic sequencing access through private laboratories, academic collaborations, and oncology-focused testing, while Brazil anchors Latin American demand through cancer centers, infectious disease research, biobanking activity, and academic genomics capacity.

In Europe, the United Kingdom benefits from Genomics England, the NHS Genomic Medicine Service, and UK Biobank’s 500,000-participant resource, all of which reinforce demand for standardized sequencing sample preparation. Germany combines hospital-based molecular diagnostics with a strong life sciences and clinical research environment, while France supports national genomic medicine programs and structured healthcare innovation. Italy and Spain are scaling oncology, rare disease, and translational sequencing applications through hospital networks and research institutes, and Russia maintains research-oriented NGS use under constrained supply and procurement conditions.

China is a major force in sequencing scale, domestic genomics capacity, reproductive health, oncology, infectious disease research, and population genomics. India is expanding through lower-cost diagnostics, rare disease awareness, infectious disease sequencing, and growing private laboratory networks. Japan emphasizes high-quality clinical research, cancer genomics, pharmacogenomics, and aging-related precision medicine, while South Korea integrates advanced hospitals, biobanks, digital health capabilities, and strong biomedical research infrastructure. Australia is notable for public genomics initiatives, cancer research networks, rare disease programs, and strong translational medicine adoption across academic and healthcare settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflow reliability, automation compatibility, and evidence-based performance claims. Products that demonstrate reproducible library yields, low duplicate rates, contamination control, broad sample compatibility, and robust performance with low-input or degraded specimens are better positioned for clinical and translational laboratories using next-generation sequencing sample preparation at scale.

Organizations should also align development with regulated clinical use by investing in documentation, validation support, lot consistency, assay transferability, and interoperability with laboratory information management systems. Strategic partnerships with sequencer platform providers, liquid handling automation specialists, hospitals, biobanks, public health laboratories, and biopharma developers can accelerate adoption. Suppliers should build region-specific access strategies that account for reimbursement pathways, import requirements, laboratory accreditation, workforce training, service responsiveness, and localized technical support.

Research Methodology

This executive summary is developed using a structured research methodology combining secondary research, regulatory review, technology mapping, and demand-signal triangulation. The analysis draws on publicly available information from health agencies, clinical genomics programs, peer-reviewed literature, product documentation, regulatory guidance, and recognized public initiatives such as NIH programs, UK Biobank, Genomics England, and national genome projects.

Insights are validated by comparing adoption signals across applications, sample types, end users, regions, and regulatory environments. The methodology emphasizes verifiable developments rather than speculative estimates, with particular attention to workflow adoption, automation trends, clinical utility, public funding, quality management requirements, and laboratory implementation patterns in next-generation sequencing sample preparation.

Conclusion

NGS sample preparation is moving from a supporting laboratory step to a defining component of sequencing performance, clinical reliability, and operational scalability. As sequencing becomes more embedded in oncology, inherited disease testing, infectious disease surveillance, reproductive health, pharmacogenomics, and population genomics, demand will continue to favor workflows that are standardized, automated, data-informed, and compatible with diverse sample inputs.

The strongest competitive positions will belong to organizations that combine robust wet-lab chemistry with automation, AI-enabled quality control, clinical validation support, and regional execution. For laboratories and suppliers alike, the future of next-generation sequencing will be shaped not only by sequencing throughput, but by the quality, consistency, and traceability of the libraries prepared before the run begins.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Next-Generation Sequencing Sample Preparation Market, by Product
7.1. Instruments
7.2. Reagents & Consumables
7.3. Services
8. Next-Generation Sequencing Sample Preparation Market, by Workflow
8.1. Library Preparation & Amplification
8.2. Library Quantification/QC
8.3. Nucleic Acid Extraction
8.4. Target Enrichment
9. Next-Generation Sequencing Sample Preparation Market, by NGS Technology
9.1. ChIP Sequencing
9.2. Exome Sequencing
9.3. Methylation Sequencing
9.4. RNA Sequencing (RNA-Seq)
9.5. Targeted Sequencing
9.6. Whole Genome Sequencing (WGS)
10. Next-Generation Sequencing Sample Preparation Market, by Sample Type
10.1. DNA
10.2. RNA
11. Next-Generation Sequencing Sample Preparation Market, by Application
11.1. Agricultural Genomics
11.2. Animal Science & Veterinary Research
11.3. Clinical Diagnostics
11.4. Clinical Research & Drug Development
11.5. Consumer Genomics
11.6. Forensics
12. Next-Generation Sequencing Sample Preparation Market, by End User
12.1. Academic & Research Institutions
12.2. Hospitals & Clinics
12.3. Pharmaceutical & Biotechnology Companies
13. Asia-Pacific Next-Generation Sequencing Sample Preparation Market
14. North America Next-Generation Sequencing Sample Preparation Market
15. Latin America Next-Generation Sequencing Sample Preparation Market
16. Europe Next-Generation Sequencing Sample Preparation Market
17. Middle East Next-Generation Sequencing Sample Preparation Market
18. Africa Next-Generation Sequencing Sample Preparation Market
19. ASEAN Next-Generation Sequencing Sample Preparation Market
20. GCC Next-Generation Sequencing Sample Preparation Market
21. European Union Next-Generation Sequencing Sample Preparation Market
22. BRICS Next-Generation Sequencing Sample Preparation Market
23. G7 Next-Generation Sequencing Sample Preparation Market
24. NATO Next-Generation Sequencing Sample Preparation Market
25. United States Next-Generation Sequencing Sample Preparation Market
26. Canada Next-Generation Sequencing Sample Preparation Market
27. Mexico Next-Generation Sequencing Sample Preparation Market
28. Brazil Next-Generation Sequencing Sample Preparation Market
29. United Kingdom Next-Generation Sequencing Sample Preparation Market
30. Germany Next-Generation Sequencing Sample Preparation Market
31. France Next-Generation Sequencing Sample Preparation Market
32. Russia Next-Generation Sequencing Sample Preparation Market
33. Italy Next-Generation Sequencing Sample Preparation Market
34. Spain Next-Generation Sequencing Sample Preparation Market
35. China Next-Generation Sequencing Sample Preparation Market
36. India Next-Generation Sequencing Sample Preparation Market
37. Japan Next-Generation Sequencing Sample Preparation Market
38. Australia Next-Generation Sequencing Sample Preparation Market
39. South Korea Next-Generation Sequencing Sample Preparation Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Agilent Technologies, Inc.
41.2. Azenta Life Sciences
41.3. BGI Genomics Co., Ltd.
41.4. Biodiscovery, LLC
41.5. Bio-Rad Laboratories, Inc.
41.6. Charles River Laboratories International, Inc
41.7. Danaher Corporation
41.8. F. Hoffmann-La Roche Ltd
41.9. GenScript Biotech Corporation
41.10. Hamilton Bonaduz AG
41.11. Illumina, Inc.
41.12. LGC Biosearch Technologies
41.13. Merck KGaA
41.14. Meridian Bioscience, Inc
41.15. New England Biolabs, Inc
41.16. NimaGen B.V.
41.17. Omega Bio-tek, Inc.
41.18. Oxford Nanopore Technologies PLC
41.19. Pacific Biosciences of California, Inc.
41.20. Parse Biosciences
41.21. PerkinElmer, Inc.
41.22. Promega Corporation
41.23. QIAGEN N.V.
41.24. Standard BioTools Inc.
41.25. Takara Bio Inc.
41.26. Thermo Fisher Scientific, Inc.
41.27. Twist Bioscience Corporation
41.28. Zymo Research Corporation
List of Figures
FIGURE 1. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LIBRARY PREPARATION & AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LIBRARY PREPARATION & AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LIBRARY PREPARATION & AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LIBRARY QUANTIFICATION/QC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LIBRARY QUANTIFICATION/QC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LIBRARY QUANTIFICATION/QC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TARGET ENRICHMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TARGET ENRICHMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TARGET ENRICHMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CHIP SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CHIP SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CHIP SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EXOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EXOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EXOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL METHYLATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL METHYLATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL METHYLATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RNA SEQUENCING (RNA-SEQ) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RNA SEQUENCING (RNA-SEQ) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RNA SEQUENCING (RNA-SEQ) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AGRICULTURAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AGRICULTURAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AGRICULTURAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANIMAL SCIENCE & VETERINARY RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL SCIENCE & VETERINARY RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANIMAL SCIENCE & VETERINARY RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL RESEARCH & DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL RESEARCH & DRUG DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL RESEARCH & DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FORENSICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FORENSICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FORENSICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 109. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 110. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 123. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 124. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 130. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 131. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 137. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 138. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 152. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 158. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 159. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 161. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 165. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 166. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 179. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 180. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 187. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 189. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 192. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 193. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 194. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 196. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 200. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 201. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 203. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 207. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 208. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 210. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 214. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 215. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 217. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 220. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 222. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 228. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 229. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 231. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 235. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 236. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 238. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 242. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 243. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 245. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 249. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 250. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 252. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 256. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 257. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 259. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 263. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 264. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 266. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 270. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 271. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Next-Generation Sequencing Sample Preparation market report include:
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Biodiscovery, LLC
  • Bio‐Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Hamilton Bonaduz AG
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • Meridian Bioscience, Inc
  • New England Biolabs, Inc
  • NimaGen B.V.
  • Omega Bio-tek, Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Parse Biosciences
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.52 Billion
Compound Annual Growth Rate12.5%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

NGS Sample Preparation Market - Global Forecast 2026-2032 - Product Image

NGS Sample Preparation Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Next Generation Sequencing Market - Global Forecast 2026-2032 - Product Image

Next Generation Sequencing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report - Product Image

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

  • Report
  • 206 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation Market Report 2026 - Product Image

Next Generation Sequencing (NGS) Sample Preparation Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sample Preparation Products for Next Generation Sequencing Market Report 2026 - Product Image

Sample Preparation Products for Next Generation Sequencing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.